Peptides Biosimilars Market
1 Introduction to Research & Analysis Reports
1.1 Peptides Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptides Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptides Biosimilars Overall Market Size
2.1 Global Peptides Biosimilars Market Size: 2021 VS 2028
2.2 Global Peptides Biosimilars Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptides Biosimilars Players in Global Market
3.2 Top Global Peptides Biosimilars Companies Ranked by Revenue
3.3 Global Peptides Biosimilars Revenue by Companies
3.4 Top 3 and Top 5 Peptides Biosimilars Companies in Global Market, by Revenue in 2021
3.5 Global Companies Peptides Biosimilars Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptides Biosimilars Players in Global Market
3.6.1 List of Global Tier 1 Peptides Biosimilars Companies
3.6.2 List of Global Tier 2 and Tier 3 Peptides Biosimilars Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Peptides Biosimilars Market Size Markets, 2021 & 2028
4.1.2 Glucagon
4.1.3 Calcitonin
4.2 By Type - Global Peptides Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Peptides Biosimilars Revenue, 2017-2022
4.2.2 By Type - Global Peptides Biosimilars Revenue, 2023-2028
4.2.3 By Type - Global Peptides Biosimilars Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptides Biosimilars Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Chronic Diseases
5.1.4 Autoimmune Diseases
5.1.5 Blood Disorders
5.1.6 Growth Hormone Deficiency
5.1.7 Infectious Diseases
5.1.8 Other Diseases
5.2 By Application - Global Peptides Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Peptides Biosimilars Revenue, 2017-2022
5.2.2 By Application - Global Peptides Biosimilars Revenue, 2023-2028
5.2.3 By Application - Global Peptides Biosimilars Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Peptides Biosimilars Market Size, 2021 & 2028
6.2 By Region - Global Peptides Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Peptides Biosimilars Revenue, 2017-2022
6.2.2 By Region - Global Peptides Biosimilars Revenue, 2023-2028
6.2.3 By Region - Global Peptides Biosimilars Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Peptides Biosimilars Revenue, 2017-2028
6.3.2 US Peptides Biosimilars Market Size, 2017-2028
6.3.3 Canada Peptides Biosimilars Market Size, 2017-2028
6.3.4 Mexico Peptides Biosimilars Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Peptides Biosimilars Revenue, 2017-2028
6.4.2 Germany Peptides Biosimilars Market Size, 2017-2028
6.4.3 France Peptides Biosimilars Market Size, 2017-2028
6.4.4 U.K. Peptides Biosimilars Market Size, 2017-2028
6.4.5 Italy Peptides Biosimilars Market Size, 2017-2028
6.4.6 Russia Peptides Biosimilars Market Size, 2017-2028
6.4.7 Nordic Countries Peptides Biosimilars Market Size, 2017-2028
6.4.8 Benelux Peptides Biosimilars Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Peptides Biosimilars Revenue, 2017-2028
6.5.2 China Peptides Biosimilars Market Size, 2017-2028
6.5.3 Japan Peptides Biosimilars Market Size, 2017-2028
6.5.4 South Korea Peptides Biosimilars Market Size, 2017-2028
6.5.5 Southeast Asia Peptides Biosimilars Market Size, 2017-2028
6.5.6 India Peptides Biosimilars Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Peptides Biosimilars Revenue, 2017-2028
6.6.2 Brazil Peptides Biosimilars Market Size, 2017-2028
6.6.3 Argentina Peptides Biosimilars Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peptides Biosimilars Revenue, 2017-2028
6.7.2 Turkey Peptides Biosimilars Market Size, 2017-2028
6.7.3 Israel Peptides Biosimilars Market Size, 2017-2028
6.7.4 Saudi Arabia Peptides Biosimilars Market Size, 2017-2028
6.7.5 UAE Peptides Biosimilars Market Size, 2017-2028
7 Players Profiles
7.1 Sandoz
7.1.1 Sandoz Corporate Summary
7.1.2 Sandoz Business Overview
7.1.3 Sandoz Peptides Biosimilars Major Product Offerings
7.1.4 Sandoz Peptides Biosimilars Revenue in Global Market (2017-2022)
7.1.5 Sandoz Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Peptides Biosimilars Major Product Offerings
7.2.4 Pfizer Peptides Biosimilars Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 Teva Pahrmaceutical
7.3.1 Teva Pahrmaceutical Corporate Summary
7.3.2 Teva Pahrmaceutical Business Overview
7.3.3 Teva Pahrmaceutical Peptides Biosimilars Major Product Offerings
7.3.4 Teva Pahrmaceutical Peptides Biosimilars Revenue in Global Market (2017-2022)
7.3.5 Teva Pahrmaceutical Key News
7.4 Celltrion
7.4.1 Celltrion Corporate Summary
7.4.2 Celltrion Business Overview
7.4.3 Celltrion Peptides Biosimilars Major Product Offerings
7.4.4 Celltrion Peptides Biosimilars Revenue in Global Market (2017-2022)
7.4.5 Celltrion Key News
7.5 Biocon
7.5.1 Biocon Corporate Summary
7.5.2 Biocon Business Overview
7.5.3 Biocon Peptides Biosimilars Major Product Offerings
7.5.4 Biocon Peptides Biosimilars Revenue in Global Market (2017-2022)
7.5.5 Biocon Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Peptides Biosimilars Major Product Offerings
7.6.4 Amgen Peptides Biosimilars Revenue in Global Market (2017-2022)
7.6.5 Amgen Key News
7.7 Samsung Biologics
7.7.1 Samsung Biologics Corporate Summary
7.7.2 Samsung Biologics Business Overview
7.7.3 Samsung Biologics Peptides Biosimilars Major Product Offerings
7.7.4 Samsung Biologics Peptides Biosimilars Revenue in Global Market (2017-2022)
7.7.5 Samsung Biologics Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Peptides Biosimilars Major Product Offerings
7.8.4 Mylan Peptides Biosimilars Revenue in Global Market (2017-2022)
7.8.5 Mylan Key News
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Corporate Summary
7.9.2 Dr. Reddy's Laboratories Business Overview
7.9.3 Dr. Reddy's Laboratories Peptides Biosimilars Major Product Offerings
7.9.4 Dr. Reddy's Laboratories Peptides Biosimilars Revenue in Global Market (2017-2022)
7.9.5 Dr. Reddy's Laboratories Key News
7.10 Stada Arzneimittel AG
7.10.1 Stada Arzneimittel AG Corporate Summary
7.10.2 Stada Arzneimittel AG Business Overview
7.10.3 Stada Arzneimittel AG Peptides Biosimilars Major Product Offerings
7.10.4 Stada Arzneimittel AG Peptides Biosimilars Revenue in Global Market (2017-2022)
7.10.5 Stada Arzneimittel AG Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Peptides Biosimilars Market Opportunities & Trends in Global Market
Table 2. Peptides Biosimilars Market Drivers in Global Market
Table 3. Peptides Biosimilars Market Restraints in Global Market
Table 4. Key Players of Peptides Biosimilars in Global Market
Table 5. Top Peptides Biosimilars Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Peptides Biosimilars Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Peptides Biosimilars Revenue Share by Companies, 2017-2022
Table 8. Global Companies Peptides Biosimilars Product Type
Table 9. List of Global Tier 1 Peptides Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptides Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Peptides Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Peptides Biosimilars Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Peptides Biosimilars Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Peptides Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Peptides Biosimilars Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Peptides Biosimilars Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Peptides Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Peptides Biosimilars Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Peptides Biosimilars Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Peptides Biosimilars Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Peptides Biosimilars Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Peptides Biosimilars Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Peptides Biosimilars Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Peptides Biosimilars Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Peptides Biosimilars Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Peptides Biosimilars Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Peptides Biosimilars Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Peptides Biosimilars Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Peptides Biosimilars Revenue, (US$, Mn), 2023-2028
Table 30. Sandoz Corporate Summary
Table 31. Sandoz Peptides Biosimilars Product Offerings
Table 32. Sandoz Peptides Biosimilars Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Peptides Biosimilars Product Offerings
Table 35. Pfizer Peptides Biosimilars Revenue (US$, Mn), (2017-2022)
Table 36. Teva Pahrmaceutical Corporate Summary
Table 37. Teva Pahrmaceutical Peptides Biosimilars Product Offerings
Table 38. Teva Pahrmaceutical Peptides Biosimilars Revenue (US$, Mn), (2017-2022)
Table 39. Celltrion Corporate Summary
Table 40. Celltrion Peptides Biosimilars Product Offerings
Table 41. Celltrion Peptides Biosimilars Revenue (US$, Mn), (2017-2022)
Table 42. Biocon Corporate Summary
Table 43. Biocon Peptides Biosimilars Product Offerings
Table 44. Biocon Peptides Biosimilars Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen Peptides Biosimilars Product Offerings
Table 47. Amgen Peptides Biosimilars Revenue (US$, Mn), (2017-2022)
Table 48. Samsung Biologics Corporate Summary
Table 49. Samsung Biologics Peptides Biosimilars Product Offerings
Table 50. Samsung Biologics Peptides Biosimilars Revenue (US$, Mn), (2017-2022)
Table 51. Mylan Corporate Summary
Table 52. Mylan Peptides Biosimilars Product Offerings
Table 53. Mylan Peptides Biosimilars Revenue (US$, Mn), (2017-2022)
Table 54. Dr. Reddy's Laboratories Corporate Summary
Table 55. Dr. Reddy's Laboratories Peptides Biosimilars Product Offerings
Table 56. Dr. Reddy's Laboratories Peptides Biosimilars Revenue (US$, Mn), (2017-2022)
Table 57. Stada Arzneimittel AG Corporate Summary
Table 58. Stada Arzneimittel AG Peptides Biosimilars Product Offerings
Table 59. Stada Arzneimittel AG Peptides Biosimilars Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Peptides Biosimilars Segment by Type in 2021
Figure 2. Peptides Biosimilars Segment by Application in 2021
Figure 3. Global Peptides Biosimilars Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Peptides Biosimilars Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Peptides Biosimilars Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peptides Biosimilars Revenue in 2021
Figure 8. By Type - Global Peptides Biosimilars Revenue Market Share, 2017-2028
Figure 9. By Application - Global Peptides Biosimilars Revenue Market Share, 2017-2028
Figure 10. By Region - Global Peptides Biosimilars Revenue Market Share, 2017-2028
Figure 11. By Country - North America Peptides Biosimilars Revenue Market Share, 2017-2028
Figure 12. US Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Peptides Biosimilars Revenue Market Share, 2017-2028
Figure 16. Germany Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 17. France Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Peptides Biosimilars Revenue Market Share, 2017-2028
Figure 24. China Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 28. India Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Peptides Biosimilars Revenue Market Share, 2017-2028
Figure 30. Brazil Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Peptides Biosimilars Revenue Market Share, 2017-2028
Figure 33. Turkey Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Peptides Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 37. Sandoz Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Pahrmaceutical Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Celltrion Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biocon Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Samsung Biologics Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Mylan Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Dr. Reddy's Laboratories Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Stada Arzneimittel AG Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
